Evolution of Bioprocessing and How It Has Transformed the Biopharma Sector

When it comes to the production of drugs, the pharmaceutical sector is on the verge of a turning point. Unprecedented strain is being placed on the industry by factors such as rising cost pressures, shifts in market paradigm toward outcome-based treatment, severe rivalry, and an ever-increasing demand brought on by an ageing and growing population. The pharmaceutical industry is striving to keep up with the need for more sophisticated treatments to be produced in bigger quantities and more quickly and efficiently than ever before.

 

The future of manufacturing is being altered by enhanced processes and technological advancements at the same time that new, revolutionary biologics are revolutionising the biopharmaceutical sector. Targeted medicines are in greater demand, but their distribution still requires more effective manufacturing processes. Implementing ideas like process intensification and Industry 4.0 could be important in assisting to accomplish this.

 

The ability to treat a wide range of uncommon and difficult diseases is now being demonstrated by cell and gene therapies, which have long been predicted to represent the biopharmaceutical industry's future. As a result, over the following several years, a lot of recently commercialised medications will be produced in lesser amounts.

 

The introduction of these cutting-edge and revolutionary biopharmaceuticals and their potential for innovation excite the industry greatly. This strategy has become a reality over the past decade thanks to the growth of specific technical developments. For instance, significant improvements in cell culture efficiency have made it possible to employ smaller bioreactors. 

 

Purification processes have also been shortened as new chromatography resins were employed. Better equipment design and the adoption of single-use technologies are reducing the time taken for cleaning, maintenance, and changeovers. Over the next decade, it is expected that more and more continuous bioprocessing will be used, which could also permit more intensive, effective manufacturing.

 

Join us on 28th - 29th March, 2023 for the International Bioprocessing and Biologics Forum, in Berlin, Germany so you don't feel left out in the industry!

 

To register or learn more about the Forum please check here: https://bit.ly/3zxguXW

 

For more information and group participation, contact us: [email protected]

Comment